David Baverez

BioProtein Technologies SA develops recombinant therapeutic proteins and vaccines. Its proprietary technology offers customized packages supplying highly purified biopharmaceuticals. The firm provides pharmaceutical and biotechnology companies with integrated services from gene expression to industrial production of proteins and vaccines in milk. The company was founded on July 1, 1988 by Marc Le Bozec, Louis-Marie Houdebine, Jean-Paul Renard, Bernard Jégou and François Deneux and is headquartered in Jouy-en-Josas, France.

KDA Capital LLP (KDA Capital) is the UK alternative investment subsidiary of KDA Capital (Cayman) Ltd. The firm was established in 2005 by David Baverez and is based in London. They manage their flagship fund, the KDA Capital European Fund, for high-net worth U.S. and European individual and institutional clients. Investments in the fund, backed by Chris Hohn's hedge fund, TCI, are frozen for three years.

FIL Gestion SASU provides investment advisory services. It offers brokerage and asset management services. The company was founded in 1994 and is headquartered in Paris, France.

FIL Investment Advisors (UK) Ltd. (FIA UK) is a Great Britain-based fund management firm headquartered in Tadworth, Surrey. Founded in 1984, the firm is a wholly-owned subsidiary of FIL Holdings (UK) Limited, which in turn is a wholly-owned subsidiary of FIL Ltd. in Bermuda. FIA UK provides a range of global investment products and services to institutional accounts, mutual funds and other pooled investment vehicles.

ALPIMA Ltd. engages in the provision of investment platform. It serves the asset and wealth managers, product providers, institutional investors, and asset owners. The company was founded by Pierre Medndelsohn in 2014 and is headquartered in London, the United Kingdom.